|
|
Other links at Articles > Allergy and Clinical Immunology |
| 1. |
H1N1 Flu Skepticism Demands Deft Response
|
|
|
European scientists and health authorities are facing angry questions about why H1N1 flu has not caused death and destruction on the scale first feared, and they need to respond deftly to ensure public support. Reuters Health Information
|
| 3. |
Communicating Drug Risks to Patients
|
|
|
Besides legal concerns, there are many positive reasons to inform patients about the effectiveness and safety of the drugs they are taking. Medscape Pharmacists
|
| 4. |
FDA Safety Changes: Ambien, Primaxin IM/IV, Hepsera
|
|
|
The FDA has approved revisions to the safety labeling for zolpidem tartrate, imipenem-cilastatin intramuscular injection, imipenem-cilastatin intravenous infusion, and adefovir dipivoxil. Medscape Medical News
|
|
|
